-
Mashup Score: 2
This project will evaluate the feasibility and reproducibility of novel WB-MRI for the characterization of pre-malignant lesions in NF-1 patients.
Source: focusonneurology.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0
Artesunate (ART) is a derivative of artemisinin. Compared with artemisinin, ART has excellent water solubility, high stability and oral bioavailability. In this review, the application of ART in classic autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and ulcerative colitis is summarized. ART exhibited similar or even better efficacy than other highly effective immunosuppressive agents, such as methotrexate and cyclophosphamide. In addition, ART exerts its pharmacological effects mainly by inhibiting the production of inflammatory factors, reactive oxygen species, autoantibodies and the migration of cells to reduce damage to tissues or organs. Moreover, ART widely affected the NF-κB, PI3K/Akt, JAK/STAT and MAPK pathways to exert pharmacological effects.
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Endothelial Pannexin 1 Channels Control Inflammation by Regulating Intracellular Calcium - 5 year(s) ago
This article is featured in In This Issue , p.[2865][1] [1]: /lookup/volpage/204/2865
Source: The Journal of ImmunologyCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
The U.S. Food and Drug Administration (FDA) has approved Koselugo (selumetinib) for the treatment of patients, 2 years of age and older, that have neurofibromatosis type 1 (NF1) with inoperable plexiform neurofibromas.
Source: CheckRare.comCategories: Hem/Onc News and JournalsTweet
Neurofibromatosis Type 1 (#NF-1) patients can develop benign tumors, plexiform neuromas (PN), that may transform into malignant peripheral nerve sheath tumors (MPNST). https://t.co/aPWe9kxO9w? https://t.co/miti5wBLsg